Buprenorphine and Methadone Reduce Opioid Overdoses But Are Underused

    A new study finds methadone and buprenorphine are highly effective in treating opioid use disorder and reducing overdoses, but these treatments are underused by physicians.

    Researchers compared various approaches to dealing with opioid use disorder: the use of methadone and buprenorphine; no treatment; inpatient detoxification or residential services; intensive outpatient or partial hospitalization; naltrexone; and outpatient counseling.

    The researchers found only treatment with buprenorphine or methadone led to significant decreases in overdoses and emergency department visits or hospitalizations at three and 12 months of follow-up, The Pew Charitable Trusts reports.

    The study found only a small number of people can access these treatments, largely because of lack of access to doctors authorized to prescribe the medications, high co-payments, prior authorization requirements and other restrictions on use.

    COVID-19: Help in Accessing Critical Medications for Your Loved One

    For those using or considering pharmacotherapy, also known as medication-assisted treatment, to treat opioid use disorder, we have guidance to help ensure there is no lapse in care due to COVID-19 circumstances.

    Learn more
    By Partnership Staff
    March 2020

    Published

    March 2020

    We use cookies to improve your experience and serve you relevant information. To learn more, read our privacy policy.